HuGE Literature Finder
Records
1
-
5
MTHFR C677T, Prothrombin G20210A, and Factor V Leiden (G1691A) Polymorphism and Beta-Thalassemia Risk: A Meta-Analysis. Cureus 2020 11 12 (9): e10743. Nigam Nitu, Singh Prithvi K, Agrawal Monica, Nigam Sanjay, Gupta Harish, Saxena Shailend |
Hypercoagulable state and methylenetetrahydrofolate reductase (MTHFR) C677T mutation in patients with beta-thalassemia major in Kuwait. Acta haematologica 2010 123 (1): 37-42. Mustafa Nada Y, Marouf Rajaa, Al-Humood Salah, Al-Fadhli Suad M, Mojiminiyi Oluseg |
The prevalence of factor V Leiden (G1691A), prothrombin G20210A and methylenetetrahydrofolate reductase C677T mutations in Jordanian patients with beta-thalassemia major. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2009 Dec 20 (8): 675-8. Al-Sweedan Suleimman A, Jaradat Said, Iraqi Muna, Beshtawi Moham |
Prevalence of thrombotic risk factors among beta-thalassemia patients from Western Iran. Journal of thrombosis and thrombolysis 2008 Dec 26 (3): 229-33. Rahimi Zohreh, Ghaderi Mandana, Nagel Ronald L, Muniz Adria |
Screening for inherited thrombophilia might be warranted among Eastern Mediterranean sickle-beta-0 thalassemia patients. Journal of thrombosis and thrombolysis 2006 Oct 22 (2): 121-3. Isma'eel Hussain, Arnaout M S, Shamseddeen Wael, Mahfouz R, Zeineh N, Jradi Oussama, Taher A |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 20, 2023
- Content source: